About TIGERMED Company

Tiger Pharmaceuticals (stock code: 300347.SZ/3347.HK) is a contract research organization (CRO) that focuses on providing professional services throughout the clinical trial process for new drug development. It provides comprehensive clinical research services and solutions to innovative pharmaceutical and medical device companies around the world to reduce R&D risks, shorten the R&D cycle, save R&D expenses, promote the product marketization process, and enable patients to use newer and better pharmaceuticals and medical products as soon as possible. The company is a contract research organization (CRO) focusing on providing professional services throughout the clinical trial process for new drug development. It provides comprehensive and integrated clinical research solutions for global pharmaceutical and medical device innovators to ensure research quality, reduce R&D risks, shorten the R&D cycle, save R&D expenses, promote the product marketization process, and enable patients to use newer and better pharmaceuticals and medical products as soon as possible. Clinical trial technology services; clinical trial related services and laboratory services. Corporate honors: Lilly Global Supplier Award, MSD Supplier Outstanding Service Award, China Pharmaceutical's Top 10 Listed Companies with Investment Value, etc.